[📢Brenus Pharma and InSphero receive €1.5 million in grants from the European EUROSTARS fund for the development of a companion test for the next-generation cancer cell immunotherapy STC-1010]
![](https://brenus-pharma.com/wp-content/uploads/2024/06/InSphero_Logo-1024x537.jpg)
Brenus Pharma and InSphero receive €1.5 million in grants from the European EUROSTARS fund for the development of a companion test for the next-generation cancer cell immunotherapy STC-1010 DOWNLOAD PRÂ